Skip to main content
Clinical Trials/JPRN-UMIN000015327
JPRN-UMIN000015327
Completed
未知

A randomized controlled trial for improving effects of test food on skins in women - A randomized controlled trial for improving effects of test food on skins in women

CPCC Co.,Ltd.0 sites48 target enrollmentOctober 3, 2014
ConditionsHealthy adults

Overview

Phase
未知
Intervention
Not specified
Conditions
Healthy adults
Sponsor
CPCC Co.,Ltd.
Enrollment
48
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 3, 2014
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
CPCC Co.,Ltd.

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\)These prescreened medicine. (2\)These having Food for Specified Health Uses (FOSHU) and/or health food. (3\)Subjects who have previous medical history and/or current medical history of serious diseases (e.g., heart, liver, kidney and/or digestive organ). (4\)Pregnant women, lactating women, or women who want to get pregnant during the trial period (5\)Heavy alcohol drinker. (6\)Those that have extremely disheveled lifestyle and/or dietary habits. (7\)Subjects who have previous medical history of drug and/or food allergy. (8\)Subjects who have skin allergy such as the atopy. (9\)Subjects with more than of number of cigarettes smoked an average of 21 per day (10\)Subjects who have been participated in another trial or other investigational and/or enrolled in the other clinical trials within about last 1 month. (11\)Subjects who have treated cosmetic care(e.g., electric facials, esthetic, peeling and/or laser medical treatment). (12\)Subjects who have donated over 200 mL of blood and/or blood components within the last one month prior to the current study. (13\)Subjects who have donated over 400 mL of blood and/or blood components within the last four months prior to the current study. (14\)Subjects who collected blood amount of blood sampling over 800 mL within the last twelve months prior to the current study and this clinical trial's blood sampling. (15\)Subjects who have been determined ineligible by principal investigator or sub\-investigator.

Outcomes

Primary Outcomes

Not specified

Similar Trials